Macquarie suggested a target price of Rs 7,400 for Divis Labs, Rs 1,500 for Suven Pharma, Rs 835 for Syngene and Rs 1,000 for ...

The Nifty Pharma index dropped as much as 2% in early trade. Sun Pharma fell nearly 2%, Dr Reddy’s dropped as much as 4%, and ...

An index of Indian pharmaceutical company shares slid 2% to its lowest level in seven months on Wednesday after U.S.

Defence Secretary Rajesh Kumar Singh said relaxation in Foreign Direct Investment (FDI) policy and industrial licensing ...

The Q3FY25 results for mid and small cap companies saw more downgrades compared to large caps against the previous quarter, ...

Although domestic cotton prices remain higher than international prices, the overall demand scenario seems to be improving ...

Stocks in the Nifty Pharma index were down by as much as 6% following US President Donald Trump's proposal to impose tariffs; ...

The decline in pharma stocks followed comments from President Donald Trump, who indicated that the US may impose tariffs of ...

Several companies capitalised on the bullish momentum in green energy stocks to launch IPOs and fund expansions. Here’s what ...

With consumer-facing bookings becoming increasingly expensive, the online travel giant is turning to businesses, targeting a ...

The Nifty index opened flat, and witnessed selling pressure in the first half, but saw a sharp recovery in the second half, ...

India's mobile phone manufacturing industry has reached an unprecedented milestone, with exports soaring to a record Rs 1.5 ...